{
    "clinical_study": {
        "@rank": "109450", 
        "arm_group": {
            "arm_group_label": "Testosterone Gel (FE 999303)", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and\n      safety of FE 999303 (Testosterone Gel) in adult hypogonadal males."
        }, 
        "brief_title": "A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Adult Male Hypogonadism", 
        "condition_browse": {
            "mesh_term": [
                "Hypogonadism", 
                "Eunuchism"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males between 18-75 years of age\n\n          -  Two serum testosterone levels <300 ng/dL\n\n        Exclusion Criteria:\n\n          -  Previous use of the study drug\n\n          -  History of prostate or breast cancer\n\n          -  Prostate-Specific Antigen (PSA) \u22653 ng/dL\n\n          -  Subject is sexually active and not willing to use adequate contraception"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "142", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02149264", 
            "org_study_id": "000127"
        }, 
        "intervention": {
            "arm_group_label": "Testosterone Gel (FE 999303)", 
            "description": "Testosterone Gel delivered using an applicator", 
            "intervention_name": "Testosterone Gel (FE 999303)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Testosterone", 
                "Testosterone enanthate", 
                "Testosterone undecanoate", 
                "Testosterone 17 beta-cypionate", 
                "Methyltestosterone"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 26, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Huntsville", 
                        "country": "United States", 
                        "state": "Alabama"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Newport Beach", 
                        "country": "United States", 
                        "state": "California"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wilmington", 
                        "country": "United States", 
                        "state": "Delaware"
                    }, 
                    "name": "Investigational site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Aventura", 
                        "country": "United States", 
                        "state": "Florida"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Troy", 
                        "country": "United States", 
                        "state": "Michigan"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Edison", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lawrence Township", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Poughkeepsie", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Purchase", 
                        "country": "United States", 
                        "state": "New York"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bala Cynwyd", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Mt. Pleasant", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nashville", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }, 
                    "name": "Investigational site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males", 
        "overall_contact": {
            "email": "DK0-Disclosure@ferring.com", 
            "last_name": "Clinical Development Support"
        }, 
        "overall_official": {
            "affiliation": "Ferring Pharmaceuticals", 
            "last_name": "Clinical Development Support", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The percentage of subjects whose average concentration (Cave(0-24)) serum total testosterone levels are \u2265300 and \u22641050 ng/dL", 
            "safety_issue": "No", 
            "time_frame": "Day 90"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02149264"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "The percentage of subjects whose Cave(0-24) serum total testosterone levels are \u2265300 and \u22641050 ng/dL", 
                "safety_issue": "No", 
                "time_frame": "Days 14, 35 and 56"
            }, 
            {
                "measure": "Change from baseline in International Index of Erectile Function (IIEF) score", 
                "safety_issue": "No", 
                "time_frame": "Days 35 and 90"
            }, 
            {
                "measure": "Change from baseline in Multidimensional Assessment of Fatigue (MAF) score", 
                "safety_issue": "No", 
                "time_frame": "Days 35 and 90"
            }, 
            {
                "measure": "Change from baseline in Short Form-12 Health Survey (SF-12) score", 
                "safety_issue": "No", 
                "time_frame": "Days 35 and 90"
            }, 
            {
                "description": "Pharmacokinetic parameter", 
                "measure": "Average concentration (Cave) for total testosterone and dihydrotestosterone", 
                "safety_issue": "No", 
                "time_frame": "Days 14, 35, 56 and 90"
            }, 
            {
                "description": "Pharmacokinetic parameter", 
                "measure": "Area under the concentration-time curve (AUC\u03c4) for total testosterone and dihydrotestosterone", 
                "safety_issue": "No", 
                "time_frame": "Days 14, 35, 56 and 90"
            }, 
            {
                "description": "Pharmacokinetic parameter", 
                "measure": "Time at which the maximum concentration occurs (Tmax) for total testosterone and dihydrotestosterone", 
                "safety_issue": "No", 
                "time_frame": "Days 14, 35, 56 and 90"
            }, 
            {
                "description": "Pharmacokinetic parameter", 
                "measure": "Maximum concentration observed (Cmax) for total testosterone and dihydrotestosterone", 
                "safety_issue": "No", 
                "time_frame": "Days 14, 35, 56 and 90"
            }, 
            {
                "description": "Pharmacokinetic parameter", 
                "measure": "Minimum concentration observed (Cmin) for total testosterone and dihydrotestosterone", 
                "safety_issue": "No", 
                "time_frame": "Days 14, 35, 56 and 90"
            }
        ], 
        "source": "Ferring Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ferring Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}